Zoono Group Limited is a Public Company listed on the Australian Stock Exchange (ASX: ZNO), specialising in the development, manufacture and global distribution of a suite of unique, proven, long lasting and environmentally friendly antimicrobial solutions that have a distinct competitive advantage.
Over the past 7 years, Zoono has developed many unique products (together with specific industry application protocols) that enable our customer partners and distributors to realise and maximise revenue producing and commercial opportunities for these products and services.
Zoono Group has also developed (and owns) a wealth of Intellectual Property based around the “Zoono Molecule” – it’s unique antimicrobial that bonds to any surface (including hard surfaces, textiles, fabrics, skin etc) and kills pathogens including bacteria, algae, and mould. Best of all, it has proven efficacy and longevity – it does not leach and cannot diminish in strength.
Today, Zoono Group has established a global network of customers and distributors spread across many countries and territories. As the market leader in its field, Zoono Group continues to develop new products and industry applications via a strong base of scientific, technical and training support.
The foundations of the Zoono technology can be traced back to the 1910’s, and then developed further in Germany to prevent the build-up of algae on the hulls of submarines and ships to make them more fuel efficient through the water.
In 2009, CEO Paul Hyslop incorporated Zoono Group Limited after identifying other fields where this technology could be effectively applied. However, the base technology would still have several inherent problems, including a methanol stabilising agent, short shelf life and the reduction of efficacy outside a relatively small temperature window.
As a result of re-engineering the technology with guidance by chemists and scientists in California and New Zealand, Zoono products now have a shelf life of approximately 3 to 5 years. In addition, sanitisation methods maintain efficacy over a wide temperature range, while Zoono products are now water based, meeting food safety legislation from national government agencies.
Zoono today is the 9th generation of the Zoono® technology and provides the antibacterial, anti-viral, anti-fungal and anti-algal protection of a broad-spectrum antimicrobial sanitiser that continuously kills for up to a month. Zoono is safe to use around people, pets and plants alike.
Technology discovered by German scientists.
Developed as a textile additive but heavily stabilised in methanol.
Technology refined further.
Re-engineered into a water based product but with a low shelf life.
Zoono established in NZ. Developed into a 9th generation, food safe, non-toxic product. Highly effective against bacteria and viruses.
TGA, NZFSA and AsureQuality listings gained in Australiasia.
Rollout of Zoono global distributor network.
Development of retail brands. Shelf life of 3 years achieved.
Zoono products now sold in 20 countries.
United States FDA & EPA listings and Registrations.
More global regulatory approvals gained.
Zoono was listed on the ASX
Newly branded retail range launched.
New products now available globally via online store.
Managing Director / CEO
Paul’s primary responsibility, in conjunction with the Board, is to determine the strategic direction of Zoono Group. This includes identifying global sales opportunities, increasing revenues, meeting profit targets, identifying new customers and distributors, negotiating distributor and customer contracts, plus new product and brand development.
Jon’s primary responsibilities are working with the CEO in the achievement of the strategic direction of the company and in identifying new opportunities – both in product terms and new territories and customers. Jon is leading the development of a market specific, Strategic Marketing Plan for Zoono brands globally.
Jon will also coordinate the Board activities in relation to governance, appointment of Board Sub Committees, and managing the relationship with regulators.
Chief Operating Officer
Lew is responsible for the ‘day to day’ operation of Zoono. This covers all facets of the business – including Distributor liaison and training, the maintenance of the Zoono IP inventory, IT and social media.
Chief Financial Officer
Paul has substantive financial and operational experience with start up’s, small and large companies in a variety of industries. Paul has held positions of CFO for The Radio Network, Head of Finance for Middlemore Hospital, one of New Zealand’s largest Hospitals, and CFO for a NZX listed Company in the Energy business involved in manufacturing and export, Paul also held a position as Head of Banking – Finance for Westpac, New Zealand.
Paul is a Chartered Accountant and holds an MBA from Massey University.
Director of International Sales
As Director of International Sales, Lloyd Johns is responsible for the overall management of Zoono sales primarily in the Middle East and Asian markets.
Lloyd has extensive experience in sales and marketing, exporting and importing and corporate financial services and has been directly instrumental in transacting property and corporate restructuring deals involving hundreds of millions of dollars.
He has managed substantial investment funds and significant property portfolios both in New Zealand and in the United States and Canada running a committed team of professionals. relationship with regulators.
Pip is a commercially-driven marketing professional with over 10 years experience in FMCG and digital marketing.
After graduating from the University of Auckland Pip went on to successfully represent market-leading brands for large multi-national businesses across Australia and New Zealand.
Pip recently assisted with a commercial project developing one of the most advanced production lines in the world for a well-known NZ business.
Business Development (Korea and Canada)
Paul’s primary responsibility is to complete the regulatory process for Korea and Canada and to then develop a market specific, sales and marketing plan for each territory.
Business Development (Singapore)
Alexander is responsible for Zoono’s brand development in South East Asia (SEA) and internationally via special project avenues.
He has been active in SEA now for over 15 years specialising in Corporate Finance and Advisory work with special strengths in capital raising services and business development work representing and promoting ASEAN companies/corporates, their products and services to the emerging growth markets of the ASEAN region, West Africa and the SADC member states.
In addition to this Alexander has extensive experience focussed on developing new markets and non-traditional sales avenues for FMCG’s. He has organised high level investment/trade missions inclusive meetings with top ASEAN banks and Malaysian Minister’s for Trade & Industry and Agriculture with foreign counter parts and enjoys strong contacts and relationships in industry, finance and government.
Mark is a highly experienced microbiologist with over 30 years of expertise in the field of Hygiene, Disinfection, Infection Prevention and aligned application technologies. Marks early career focused on pathology and research into infection prevention at the Hospital Research Laboratory in the UK. Moving into the commercial sector Mark concentrated on processed food, pharmaceutical and cosmetic industries working with hygiene chemicals and equipment within Diversey – a global supplier of cleaning and disinfection chemicals and technologies. During his time at Diversey, Mark headed up the Application Specialist Team covering all business sectors. Involved with major product launches one of Mark’s highlights was the introduction of Microfibre into the NHS and a new global range of products. As the Head of Training, Mark was instrumental in the creation of the Diversey Training Academy which was responsible for the training of customer facing sales teams. Following his time at Diversey, Mark has been involved in numerous technology breakthroughs most notably the introduction of Hydrogen Peroxide Vapour (HPV) to the NHS. Whilst working as the Company Microbiologist for one of the largest FM providers in the UK, Mark recognised the need for residual antimicrobial technologies within the Health and Hygiene sectors. Mark joined Zoono in the UK to support the introduction and evolution of Zoono in the UK and EU markets.
UK Country Manager
James is responsible for the leadership, management and development of Zoono Team in the United Kingdom and driving the growth of UK and European markets. James has worked with the Zoono technology for over 3 years developing a robust understanding of the significant benefits of embracing the capabilities of Zoono.
Retiring as a senior officer in the Royal Air Force Regiment, James’ final appointment, was as the inaugural Chief of Staff of the Defence CBRN Wing and Deputy Component Commander of the Combined Joint Multi National CBRN Task Force (CJ-MN-CBRN-TF) for NATO Reaction Force 13. James, has a strong background in Critical and Strategic Asset Protection, Operational Planning, Command and Control, Force Protection, Risk Analysis and Counter Specialist Chemical, Biological, Radiological and Nuclear (CBRN) mitigation and planning.
Since retiring James has worked with emerging Bio-technologies such as rapid DNA sequencing in support of outbreak response. James provides specialist input into Hostile Environment Awareness Training supporting International Media, Government Organisations, NGO’s and Charities responding to outbreaks such as Ebola in West Africa and more recently in the DRC. James maintains his Military exposure, security clearances and experience as an Army Reserve Major in the Army Air Corps.